radionuclide-drug conjugate targeting GCC (Full-Life Technologies)

N/A

Report date: 2025/03/20 09:16:40
NME

Base Information

Drug Nameradionuclide-drug conjugate targeting GCC (Full-Life Technologies)
Drug Alias NameN/A
ClassificationSmall moleculesRadiation-emitting products > Radioactive therapeutic agent
Mechanisms of ActionHeat-stable enterotoxin receptor antagonists
TargetsHeat-stable enterotoxin receptor
Therapy Area/IndicationsPancreatic NeoplasmsStomach NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesFull Life Technologies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFull Life Technologies Ltd
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsStomach NeoplasmsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A